CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Tax Assets, Tax Deferred Expense
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Tax Assets, Tax Deferred Expense of $0 as of 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpense · last filed 2017-02-14
- 2016-12-31: Deferred Tax Assets, Tax Deferred Expense $0.00.
- 2015-12-26: Deferred Tax Assets, Tax Deferred Expense $902.00K.
- 2014-12-27: Deferred Tax Assets, Tax Deferred Expense $993.00K.
- 2013-12-28: Deferred Tax Assets, Tax Deferred Expense $1.59M.
| Period end | Deferred Tax Assets, Tax Deferred Expense |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-14 |
| 2015-12-26 | $902.00K 10-K · filed 2017-02-14 |
| 2014-12-27 | $993.00K 10-K · filed 2016-02-12 |
| 2013-12-28 | $1.59M 10-K · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |